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Abstract
Background:  In the Rehabilitation and Aged Care Services Program at Southern Health in
Victoria, saline hypodermoclysis is a relatively common method of rehydration. However, there
were questions about the safety and effectiveness of subcutaneous infusion of other fluids and, in
particular, dextrose solutions. This review aimed to assess the safety and effectiveness of
rehydration of elderly patients with subcutaneous 5% dextrose solutions compared with
intravenous 5% dextrose solutions.
Methods:  We searched the Cochrane Library, Medline, IDIS, CINAHL, Current Contents,
Premedline, Australasian Medical Index, the Joanna Briggs Institute, the US National Guideline
Clearinghouse and bibliographies of retrieved articles. Searching was undertaken in July 2003.
Studies selected were primary studies (or systematic reviews of primary studies) providing
evidence as to the effectiveness and safety of subcutaneous infusion of dextrose solutions for
rehydration of elderly patients. We included articles published in English in the last 10 years. Data
were extracted by a single researcher.
Results: From our search we identified 15 potentially relevant articles. We obtained the full text
of these articles to determine their relevance. After application of the inclusion criteria, four
articles remained for appraisal including one systematic review, two randomised controlled trials
and one cohort study.
Conclusion:  The four studies appraised all provide evidence that appropriate volumes of
subcutaneous dextrose infusions (in the form of half-normal saline-glucose 5%, 40 g/L dextrose and
30 mmol/L NaCl, or 5% dextrose solution and 4 g/L NaCl, or two-thirds 5% glucose and one-third
normal saline) can be used effectively for the treatment of dehydration, with similar rates of adverse
effects to intravenous infusion. The evidence in this area is limited, and larger randomised
controlled trials using validated outcome measures would be useful to confirm these results.
Background
Hypodermoclysis, or subcutaneous fluid infusion, was
widely used to treat dehydration in the first half of last
century. However after reports of severe adverse reactions
in the 1950s [1], predominantly resulting from infusion
of hypertonic solutions, hypodermoclysis fell into disre-
pute and then almost entirely out of use.
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A physician from Rehabilitation and Aged Care Services at
Southern Health contacted the Centre for Clinical Effec-
tiveness to ask that we investigate the safety and effective-
ness of subcutaneous dextrose solutions in dehydrated
patients aged over 65 years. In the Rehabilitation and
Aged Care Services Program saline hypodermoclysis is a
relatively common method of rehydration. However,
there were questions about the safety and effectiveness of
subcutaneous infusion of other fluids and, in particular,
dextrose solutions.
In consultation with the physician we undertook a com-
prehensive review to provide evidence to answer two
questions: "In elderly patients, is rehydration with subcu-
taneous 5% dextrose solutions associated with higher
rates of adverse events than intravenous 5% dextrose solu-
tions?" and "In elderly, patients is rehydration with sub-
cutaneous 5% dextrose solutions as effective as
intravenous 5% dextrose solutions?"
Methods
Data sources
We carried out a comprehensive search of the literature
including the Cochrane Library, Medline, IDIS, CINAHL,
Current Contents, Premedline, Australasian Medical
Index, the Joanna Briggs Institute and the United States
National Guideline Clearinghouse (Table 1). Due to the
cost of access, Embase was not searched directly, however
the Cochrane Central Register of Controlled Trials (part of
the Cochrane Library) was searched and it includes details
of controlled trials from Embase.
Our search strategy combined terms for subcutaneous
fluid infusion (hypodermoclysis, clysis, fluid therapy,
infusion, subcutaneous injection) with terms for the
administered solution (dextrose, glucose), and terms to
restrict the search to elderly participants (aged) (Table 3).
Study selection and data extraction
The clinician requested that we only include articles pub-
lished in English in the last 10 years as it was felt that arti-
cles published prior to this might not reflect current
clinical methods.
We identified a relevant systematic review published in
1997. As a result, we only appraised the systematic review
and relevant articles published after (or not included in)
the systematic review.
From our sources we identified 15 potentially relevant
articles. We obtained the full text of these articles to deter-
mine their relevance. Eleven of the articles were excluded
on the basis that they were either narrative review or edi-
torial (n = 6), evaluated in the included systematic review
(n = 2), undertaken in an inappropriate patient group (n
= 2) or were case series or case reports (n = 1).
The systematic review, two randomised controlled trials
(RCT) and one cohort study then remained and were crit-
ically appraised.
Results and discussion
The systematic review by Rochon et al [2] aimed to evalu-
ate the evidence supporting the use of hypodermoclysis to
treat dehydration in elderly patients. The review evaluated
efficacy and safety data on hypodermoclysis from 13 stud-
ies, which investigated the effects of a range of different
administered fluids, including some dextrose solutions.
The review included a limited search strategy involving
only Medline and reference lists, and provided detailed
inclusion/exclusion criteria. To be included in the review
studies had be published in English, contain original
patient data and address the infusion of fluids to treat
dehydration in adults. Articles reporting infusion of
Table 1: Data Sources (Search date)
We carried out a comprehensive search of the literature including:
• Cochrane Library (Issue 2, 2003)
 The Cochrane Database of Systematic Reviews
 Database of Abstracts of Reviews of Effects
 Cochrane Central Register of Controlled Trials
• Medline (1966 to July Week 2, 2003)
• IDIS (September, 2003)
• CINAHL (1982 to July Week 2, 2003)
• Current Contents (1993 Week 27 to 2003 Week 30)
• Premedline (July 18, 2003)
• Australasian Medical Index (July 21, 2003)
• Joanna Briggs Institute (August 18, 2003) and
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medications or contrast media were excluded, as were arti-
cles that focussed on sensitivity to hyaluronidase.
The review had a number of limitations including the
restricted search strategy and minimal assessment of
validity of included trials. Little analysis or synthesis of
results was presented and no statistical meta-analysis was
undertaken. Studies were simply grouped and discussed
according to study design.
The evidence appraised in the systematic review [2] did
not demonstrate a significant difference in absorption or
adverse events when 40 g/L dextrose with 30 mmol/L
NaCl or 5% dextrose solution with 4 g/L NaCl was deliv-
ered via SC or IV routes.
The authors did not make any specific conclusions regard-
ing dextrose solutions but concluded that hypodermocly-
sis could be used effectively for the treatment of
dehydration. They also noted that given that dehydration
is so common in the elderly, and hypodermoclysis is via-
ble in long-term care settings, it was important that a
definitive investigation of hyperdermoclysis be under-
taken. [2].
The second study, by Slesak et al [3], was a randomised
controlled trial including 96 elderly patients (mean age
85.3 years) in German hospital geriatric wards with signs
of mild to moderate dehydration needing parenteral flu-
ids, over a period of 20 months. Patients with infectious
and allergic skin diseases, generalised oedema, acute
myocardial infarction, or other medical conditions in
which the study regime would be inappropriate were
excluded. Those known to be intolerant to one of the
methods of infusion, in manifest or imminent shock,
requiring intravenous drug administration or total
parenteral nutrition, participating in another study or
who refused consent were also excluded.
Participants were block randomised to either subcutane-
ous (SC) infusion of half-normal saline-glucose 5% or
intravenous (IV) infusion of half-normal saline-glucose
5%. The groups had similar baseline characteristics. Blind-
ing of patients, clinicians or assessors was not attempted.
Data collected included nurses' and doctors' scores of fea-
sibility of the procedure, patient ratings of discomfort,
occurrence of complications and length of hospital stay. A
number of measures were also assessed before and after
therapy including blood pressure, heart rate, haematocrit,
sodium, creatinine, activities of daily living (ADL) and
orientation to person, place and time.
A large percentage of the participants did not remain in
the treatment group to which they were allocated. Patients
allocated to SC infusion changed to IV in 13 cases (27%),
11 times because of the need to administer drugs by IV
and twice as a result of poor absorption. Patients allocated
to IV infusion changed to SC infusion in 17 cases (35%).
Eight changes were due to impossibility of continuous
peripheral venous puncture, five were due to permanent
removal of cannula by the patient, the remaining four
were made for miscellaneous reasons. An intention-to-
treat analysis was undertaken. As a result of the significant
movement between treatment groups (in both direc-
tions), the results of four groups (IV only, IV/SC, SC only,
SC/IV) were also compared.
The degree of movement between treatment groups in this
study introduces substantial opportunity for bias. Charac-
teristics of the patients who changed groups were not pro-
vided, so it is difficult to assess whether they were
representative of the wider population or a particular sub-
Table 2: Details of Included Studies
Study No of Patients Type of Study Conclusions Appraiser's Comments
Rochon et al 1997 [2] 13 studies included Systematic Review Hypodermoclysis of 40 g/L dextrose 
and 30 mmol/L NaCl or 5% dextrose 
solution and 4 g/L NaCl is safe and 
effective
Limited search strategy. Minimal 
appraisal of validity of included studies.
Slesak et al 2003 [3] 96 Randomised Controlled Trial Hypodermoclysis of half-normal 
saline-glucose 5% is well accepted by 
elderly patients and is of comparable 
efficacy and safety to IV rehydration.
Large number of switches between 
treatment groups and used non-
validated measures of discomfort and 
feasibility.
O'Keeffe & Lavan 1996 [4] 60 Randomised Controlled Trial SC or IV infusion have comparable 
efficacy and safety. SC infusion is 
better tolerated by elderly confused 
patients
Data on dextrose solutions not 
reported separately. No blinding.
Dasgupta, Binns & Rochon 2000[5] 55 Cohort Study Hypodermoclysis with two-thirds 5% 
glucose and one-third normal saline or 
normal saline was as effective as IV 
infusion and associated with local 
reactions and complications.
Substantial methodological 
weaknesses. Allocation to treatment 
based on physician preference, small 
sample size in IV group, non-validated 
outcome measures.BMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/2
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group. Results were presented as medians with range or
interquartile range. The study employed measures of fea-
sibility and discomfort that were not validated which
weakens the validity of the conclusions.
In the RCT conducted by Slesak et al [3], median length of
hospital stay and duration of fluid infusion did not vary
significantly between patients having IV and SC infusions,
however the median (minimum; maximum) volume of
IV infusions was significantly greater than SC infusions
(1000(500;1500) mL/d, 750(457; 1500) mL/d, p =
0.002). Using intention-to-treat analysis, there was no dif-
ference in patient discomfort or nurses' feasibility score
between the two treatment groups. Doctors rated SC infu-
sion as significantly more feasible than IV infusion (SC:
median = 2 (IQR:1.25–2), IV: 2(2–3.875), p = 0.011).
Clinical and laboratory measures were not significantly
different between groups and there were no significant
differences between type or frequency of side effects in the
two groups.
The authors concluded that rehydration by SC and IV
infusion were equally well accepted by geriatric patients,
similarly feasible and comparably safe and effective. They
also noted the usefulness of SC infusion in confused
patients and in those in whom IV punctures are difficult
to achieve. [3].
O'Keeffe and Lavan [4] also carried out a RCT of subcuta-
neous fluids in elderly hospital patients in Britain. In this
study the 60 participants (mean age 80 years) were cogni-
tively impaired patients admitted to an acute geriatric unit
who required parenteral fluids for at least 48 hours
because of mild dehydration on poor oral intake. Patients
were excluded if they required IV medications, if more
than 2 litres of fluid was required in a 24 hour period, if
there was clinical evidence of poor tissue perfusion or if
the precise amount of fluid administered was judged to be
critical (ie as a result of renal or heart failure).
The participants were randomly allocated to SC infusion
or IV infusion. In both treatment groups, patients received
either 0.9% saline, 0.45% saline or 5% dextrose. The two
groups had similar baseline characteristics. The amount of
fluid prescribed, amount of fluid administered, patient
agitation, number of cannula required, serum urea and
creatinine were measured.
Blinding was not undertaken. Participants were ran-
domised to treatment groups in blocks of six. A sealed
envelope containing the treatment allocation was opened
after a patient had been entered into the study. One
patient switched from IV to SC fluids due to difficulty
gaining venous access and one patient in the SC group
died for reasons unrelated to the infusion. These two
patients were excluded from the analysis. Data was pro-
vided for a mixed sample of infusion fluids, data on dex-
trose administration was not reported separately.
In contrast with Slesak et al [3], the RCT by O'Keeffe and
Lavan [4] found no significant difference in the amount of
fluid or the proportion of prescribed mean (standard
deviation) volume administered by IV as compared to SC
infusion (0.76(0.14) litres vs 0.82(0.12) litres, p = 0.1).
There was also no significant difference found between
serum creatinine or urea between the two groups. Agita-
tion relating to the drip or cannula was noted in 11 (37%)
of the patients on SC fluids and 24 (80%) of the patients
on IV fluids (RR 0.46, 95%CI(0.28 – 0.76), p = 0.0007).
Re-siting of the infusion was required in four (13%) of the
SC group and seven (23%) of the IV group, however this
difference was non-significant (RR 0.57, 95%CI(0.19 –
1.75), p = 0.32). Local oedema was noted in two patients
receiving subcutaneous fluids, no other complications
were noted.
The authors concluded that study demonstrated the
advantages of SC infusion in elderly, cognitively impaired
patients with relatively mild dehydration. They noted that
Table 3: Search Strategy for Medline (Similar terms were used in other databases)
1 (Hypodermoclysis or clysis).mp
2 Fluid therapy/or rehydration.mp
3 Exp Infusions, parenteral/
4 Exp Injections, subcutaneous/
5 Dehydration/
6o r / 1 – 5
7 Exp Glucose/or glucose.mp
8 Dextrose.mp
97  o r  8
10 Exp Aged/or elderly.mp
11 6 and 9 and 10
12 Limit 11 to (human and English language and yr = 1993–2003)BMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/2
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patients were less likely to attempt to interfere with SC
infusions.
The fourth study identified (Dasgupta, Binns and Rochon
[5]) was a cohort study of subcutaneous fluid infusion in
a long-term care setting in Toronto, Canada. In this obser-
vational study, 55 residents of a long-term care facility
were treated with fluid therapy during a five week period.
To be included, patients had to receive either SC or IV flu-
ids during the five week study period. Patients with only
one eight-hour shift of fluid therapy, and those receiving
medications through hypodermoclysis were excluded, as
were those who received blood products and those with
life-threatening conditions.
Thirty-seven of the patients received hypodermoclysis,
nine received IV fluids, and nine received both. Fluids
infused by hypodermoclysis were two-thirds 5% glucose
with one-third normal saline, or normal saline. Intrave-
nous fluid therapy consisted of administration of two-
thirds 5% glucose with one-third normal saline, half-nor-
mal saline or normal saline. No blinding was undertaken
and allocation to treatment group was dependent on phy-
sician preference. The treatment groups differed in size
and only limited data on baseline characteristics of the
groups were provided.
The authors measured occurrence and type of adverse
effects, clinical or laboratory evidence of hydration
improvement, including correction of hypernatremia, or
reduction in the BUN/creatinine ratio to <25.
This study had a number of substantial methodological
weaknesses. Allocation to treatment based on physician
preference introduces considerable opportunity for bias
and this is increased by the limited analysis of baseline
differences between treatment groups. The small sample
size, particularly in the IV group (n = 9), is another weak-
ness of this study. All patients having chronic treatment
received SC fluids. The lack of comparison with fluid ther-
apy by IV in patients in this group limits the value of data
from this part of the study. Additionally, pre-treatment
laboratory evidence of dehydration was only present in
five (18%) patients on hypodermoclysis for acute treat-
ment introducing a ceiling effect that limits the ability of
the study to observe an improvement in hydration status.
Use of non-validated measures of improvement ("gen-
eral" and "clinical" improvement) further limits validity
of results, as does the reporting of data including a variety
of administered fluids.
Similarly to the article by O'Keeffe and Lavan [4], the
results of the cohort study [5] showed no significant dif-
ferences between the IV and SC groups for general
improvement, clinical improvement or laboratory
improvement. Patients receiving hypodermoclysis had a
significantly lower mean number of complications per
day (SD) (0.07(0.16), 0.21(0.25), p = 0.04) and a signifi-
cantly lower mean (±SD) number of local reactions per
day of therapy (0.05(0.10), 0.20(0.25), p = 0.02). There
were no significant differences between the groups in
regard to the mean number of attempts to remove the
catheter or mean number of possible fluid overload epi-
sodes per day of therapy.
Dasgupta, Binns and Rochon [5] concluded that SC infu-
sion was a safe alternative to IV fluids treatment for elderly
residents in a long-term care setting with mild to moder-
ate dehydration.
Conclusions
The four reviewed studies, including one systematic
review and two randomised-controlled trials, as well as
one less methodologically rigorous study, all provide evi-
dence that appropriate volumes of subcutaneous dextrose
infusions (in the form of half-normal saline-glucose 5%,
40 g/L dextrose and 30 mmol/L NaCl, or 5% dextrose
solution and 4 g/L NaCl, or two-thirds 5% glucose and
one-third normal saline) can be used effectively for the
treatment of dehydration in elderly patients, with similar
rates of adverse effects to intravenous infusion.
However, the evidence in this area is limited and the stud-
ies appraised each have methodological flaws that limit
the strength of the conclusions that can be drawn. Larger,
methodologically rigorous, randomised controlled trials
using validated outcome measures would be useful to
confirm these results.
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